Filing Details
- Accession Number:
- 0001513162-23-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-30 11:36:42
- Reporting Period:
- 2023-01-26
- Accepted Time:
- 2023-01-30 11:36:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 73290 | Biomerica Inc | BMRA | In Vitro & In Vivo Diagnostic Substances (2835) | 952645573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821432 | Catherine Coste | 17571 Von Karman Ave Irvine CA 92614 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-26 | 2,190 | $2.96 | 43,790 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Open Market Purchase
Billionaire Hedge Funds
